← Leaderboards
Ryan McNeil
Simon Fraser University
$4,391,348
Attributed
$8,308,113
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2017–25$2.5M$1.9M$1.3M$625K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,308,113 · 4
By mechanism
R01$7,833,530 · 3
R21$474,583 · 1
Top collaborators
- Thomas Kerr8 shared
- Will Small6 shared
- Kelly Ray Knight2 shared
Others in their field
Other Emerging Leaders on “Response”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$195,683,539
- Kimberly Smith · Ppd Development Lp$115,671,664
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$70,992,558
Research focus
ResponseDrug UsageSamplingInterviewShapesProgramsEnvironmentFundingEpidemiology StudyEthnographyInnovationNational Institute Of Drug AbuseTreatment OutcomeDrug UserCanadaEpidemiologyCohort StudiesOverdoseLongitudinal Cohort StudyPharmaceutical PreparationsBehavioralFentanylInterdisciplinary StudyNorth America
Grant awards (18)
An ethno-epidemiological study of the implementation and effectiveness of an innovative and comprehensive response to the evolving overdose epidemic$572,546
R01 · FY2025 · DA
Xylazine exposure and transitions to low-frequency injecting and injection cessation$207,841
R21 · FY2025 · DA · contact PI
An ethno-epidemiological study of the implementation and effectiveness of an innovative and comprehensive response to the evolving overdoseepidemic$564,980
R01 · FY2024 · DA
Xylazine exposure and transitions to low-frequency injecting and injection cessation$266,742
R21 · FY2024 · DA · contact PI
An ethno-epidemiological study of the implementation and effectiveness of an innovative and comprehensive response to the evolving overdoseepidemic$573,673
R01 · FY2023 · DA
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)$161,497
R01 · FY2023 · DA · contact PI
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness$2,499,566
R01 · FY2022 · DA · contact PI
An ethno-epidemiological study of the implementation and effectiveness of an innovative and comprehensive response to the opioid epidemic$342,359
R01 · FY2021 · DA · contact PI
An ethno-epidemiological study to advance HIV prevention and treatment for PWUD$323,333
R01 · FY2021 · DA
An ethno-epidemiological study to advance HIV prevention and treatment for PWUD$107,479
R01 · FY2021 · DA
An ethno-epidemiological study of the implementation and effectiveness of an innovative and comprehensive response to the opioid epidemic$342,359
R01 · FY2020 · DA · contact PI
An ethno-epidemiological study to advance HIV prevention and treatment for PWUD$328,301
R01 · FY2020 · DA
An ethno-epidemiological study of the implementation and effectiveness of an innovative and comprehensive response to the opioid epidemic$344,167
R01 · FY2019 · DA · contact PI
An ethno-epidemiological study to advance HIV prevention and treatment for PWUD$329,543
R01 · FY2019 · DA
An ethno-epidemiological study of the implementation and effectiveness of an innovative and comprehensive response to the opioid epidemic$342,359
R01 · FY2018 · DA · contact PI
An ethno-epidemiological study to advance HIV prevention and treatment for PWUD$329,543
R01 · FY2018 · DA
An ethno-epidemiological study of the implementation and effectiveness of an innovative and comprehensive response to the opioid epidemic$346,008
R01 · FY2017 · DA · contact PI
An ethno-epidemiological study to advance HIV prevention and treatment for PWUD$325,817
R01 · FY2017 · DA